CASTLE BIOSCIENCES, INC. (CSTL) Operating income 2018–2025
CASTLE BIOSCIENCES, INC. (CSTL) annual operating income history from SEC filings — each fiscal year as reported.
-$42.8MFY2025 · since FY2018: -$3.8M → -$42.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$42.8M | -593.8% |
| FY2024 | $8.7M | +112.8% |
| FY2023 | -$68.0M | +6.7% |
| FY2022 | -$72.9M | -81.8% |
| FY2021 | -$40.1M | -512.6% |
| FY2020 | -$6.5M | -189.3% |
| FY2019 | $7.3M | +291.0% |
| FY2018 | -$3.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CSTL financial trends
CSTL RevenueCSTL Net incomeCSTL Net marginCSTL Gross profitCSTL Gross marginCSTL Operating marginCSTL Operating cash flowCSTL Free cash flowCSTL Capital expendituresCSTL Return on equityCSTL Stock buybacksCSTL Dividends paidCSTL Total assetsCSTL Total liabilitiesCSTL Shareholders’ equityCSTL overview →